Down syndrome
Down syndrome (trisomy of chromosome 21) is a chromosomal genetic disorder; in addition to external developmental features, its main clinical manifestations include mental and speech developmental delay, reduced immunity, endocrine and cardiac disorders, and gastrointestinal diseases. People with Down syndrome have an increased risk of developing oncological diseases, and life expectancy is significantly reduced compared to the general population.
The clinical picture and degree of neurological impairment in children with Down syndrome vary significantly. Some children can attend regular schools, have self-care skills, and find employment, while others are deeply disabled with severe mental retardation and absence of speech.
The diversity of clinical manifestations of Down syndrome is associated not so much with genetic features as with the severity of concomitant immunological and metabolic disorders.
In addition to standard medical check-ups (vision control, ultrasound of the heart and internal organs), we conduct additional laboratory tests, including studies of intestinal microbiota, antigenic load, viral and bacterial infection, measuring the concentration of vitamins and amino acids in the blood, and also assess the level of metabolic disorders.
The biomedical correction program is built individually, depending on the severity of laboratory changes, and laboratory monitoring is carried out at intermediate stages of treatment.
Special attention is paid to the study and correction of the patient's micronutrient and hormonal status.
Recently, Down syndrome has been considered as a state of mitochondrial dysfunction; accordingly, drug therapy should be built within this concept. The effectiveness of the ketogenic diet has also been demonstrated; the diet was used not only as a way to combat obesity, but also as a method of metabolic correction.
When using the ketogenic diet, improvement in cognitive status, increased physical activity, and reduced levels of inflammation are observed.
The introduction of the ketogenic diet for people with mitochondrial diseases is carried out at the clinic, under medical supervision. The use of the KETOMIT program, in addition to introducing the ketogenic diet, adapting the child to ketosis, and training parents, includes mitochondrial therapy programs – interval hypoxic therapy.
In addition, periodic use of the REMIT program allows increasing the energy capacity of mitochondria, which in turn enhances the activity of brain neurons, strengthens muscles, and boosts immunity.